Dr. Chatterjee is the Founder and Chairman of ‘The Chatterjee Group’, a multi-billion dollar global investment conglomerate head-quartered in New York and the sponsor of ‘TCG Lifesciences Private Limited’. He founded the TCG Lifesciences in 1998. He is responsible for providing strategic direction and guidance for the growth of our company. He has over 35 years of industry experience. He is also a founder member of ‘Indian School of Business’, Hyderabad and a member of the governing council of ‘Public Health Foundation of India’. Prior to forming the TCG Group, Dr Chatterjee was advisor to the Soros Fund Management and responsible for over USD 3 Billion in global investments. He holds a B. Tech. from Indian Institute of Technology, Kharagpur. He also holds a M.S. and PhD in operations research from the University of California, Berkley.

Swapan Bhattacharya is the Managing Director of our company. Mr. Bhattacharya is responsible for the executive leadership and overall management of the company. He has been associated with the TCG group since 1995 and has spear headed the group’s investments in India and its foray into life sciences from 1998. He has over 30 years of experience in national and international organizations. Prior to joining us, he has held positions with Paine Webber Inc. as Senior Vice President; and with the US Nuclear Regulatory Commission. In January 2009 has been awarded ‘Udyog Rattan’ Award by Institute of Economic Studies, India for his outstanding contribution in India’s industrial development. He is also the Co-Chairman of the biotechnology committee of Federation of Indian Chambers of Commerce and Industry ("FICCI"). He holds a bachelor’s degree in technology from the Indian Institute of Technology, Kharagpur, a master of sciences from the Virginia Polytechnic Institute and State University, U.S.A and a degree in Master of Business Administration from Kellogg School of Management, Northwestern University, U.S.A.

Dr. Goutam Das did his Ph.D. in molecular biology at the Univ of Calcutta and post-doctoral studies at Univ of Rochester, NY, USA. Dr. Das joined as a senior scientist at Astra Research Centre India, Bangalore (later known as Astra Zeneca R&D Bangalore) in 1988. Dr. Das left ARCI in 1994 to set up Syngene Intl Pvt Ltd, Asia’s first CRO/CDMO at the invitation of Dr. Kiran Mazumdar Shaw, the founder of Biocon group. During his tenure of seventeen years from 1994 till 2010 end, Syngene remained India’s premiere CRO/CMDO. Dr. Das was the COO of Syngene reporting to KMS and the board. Dr. Das was also one of the six members of the Biocon Senior Management team. Later Dr. Das joined the board of Premas Biotech Limited, Gurugram, Haryana, India and he is still with Premas in that capacity. Dr. Das has served many other companies like MMV, Switzerland and TojoVikas Pvt Ltd, Bangaloreas senior advisor and currently associated with Biomoneta, Bangalore as an advisor. Dr. Das has been associated with TCGLS since 2011.

He has 23 years of experience in corporate finance, M&A, working capital, investor relations, accounting & audit, taxation, foreign exchange, systems development of large corporate houses as well as start-ups. Pratap has operating experience of steel, ferro alloys, paper and plywood. At TCG, he is associated with petrochemicals, life sciences, real estate and financial services businesses. He is a post-graduate in commerce from Calcutta University and a member of the Institute of Chartered Accountants of India.